AJMC July 18, 2024
Andrew Cournoyer, senior vice president and director of the access experience team at Precision AQ, discusses the benefits of introducing payers into clinical trials for new medications in the earlier stages of development to help with proper evaluation.
This transcript has been lightly edited.
Transcript
What are some benefits of having payers involved in clinical research earlier?
I think there’s a lot of benefits to having payers involved earlier upfront in the process, and Doug definitely touched upon some of them. It’s kind of a 2-pronged approach to it, or 2-pronged benefit package. One, payers have a source of data that’s not being tapped into in terms of supporting earlier enrollment options, in terms of identifying patients that could be...
Today's Sponsors
Today's Sponsor